Skip to main content
SpringerLink
Log in

New developments in lymphoma clinical trials

  • Clinical Trials Review
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. The Non-Hodgkin’s Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood 1997, 89:3909–3918.

    Google Scholar 

  2. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: a progress report. Am J Clin Pathol 1999, 111(suppl 1):S8-S12.

    PubMed  CAS  Google Scholar 

  3. Armitage JO, Weisenburger DD: New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. J Clin Oncol 1998, 16:2780–2795.

    PubMed  CAS  Google Scholar 

  4. Freedman AS, Neuberg D, Gribben JG, et al.: High-dose chemoradiotherapy and anti-B cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. J Clin Oncol 1998, 16:13–18.

    PubMed  CAS  Google Scholar 

  5. Khouri IS, Ramaguera J, Kantarjian H, et al.: Hyper-CVAD and high dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle cell lymphoma. J Clin Oncol 1998, 16:3803–3809.

    PubMed  CAS  Google Scholar 

  6. Lister TA, Crowther D, Sutcliff SB, et al.: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol 1989, 7:1630–1636.

    PubMed  CAS  Google Scholar 

  7. Cheson D, Horning SJ, Coiffier B, et al.: Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. J Clin Oncol 1999, 17:1244–1253.

    PubMed  CAS  Google Scholar 

  8. Diehl V, Franklin J, Hasenclever D, et al.: BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin’s lymphoma: interim report from a trial of the German Hodgkin’s lymphoma study group. J Clin Oncol 1998, 16:3810–3821.

    PubMed  CAS  Google Scholar 

  9. Bartlett NL, Rosenberg SA, Hoppe RT, et al.: Brief chemotherapy, Stanford V and adjuvant radiotherapy for bulky or advanced-stage Hodgkin’s disease: a preliminary report. J Clin Oncol 1995, 13:1080–1088.

    PubMed  CAS  Google Scholar 

  10. Canellos GP, Anderson JR, Propert KJ, et al.: Chemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992, 327:1478–1484.

    Article  PubMed  CAS  Google Scholar 

  11. Duggan D, Petroni G, Johnson J, et al.: MOPP/ABV versus ABVD for advanced Hodgkin’s disease—a preliminary report of CALGB 8952 (with SWOG, ECOG, NCIC) [abstract]. Proc ASCO 1997, 16:12a.

    Google Scholar 

  12. Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin’s disease: International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med 1998, 339:1506–1514.

    Article  PubMed  CAS  Google Scholar 

  13. Brice P, Bastian Y, Lepage E, et al.: Comparison in low-tumorburden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe D’Etude des Lymphomes Folliculaires. J Clin Oncol 1997, 15:1110–1117.

    PubMed  CAS  Google Scholar 

  14. The International non-Hodgkin’s Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 1993, 329:987–994.

    Article  Google Scholar 

  15. Fisher RI, Gaynor ER, Dahlberg S, et al.: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 1993, 328:1002–1006.

    Article  PubMed  CAS  Google Scholar 

  16. Janicek M, Kaplan W, Neuberg D, et al.: Early restaging gallium scans predict outcome in poor prognosis patients with aggressive non-Hodgkin’s lymphoma treated with high-dose CHOP chemotherapy. J Clin Oncol 1997, 15:1631–1637.

    PubMed  CAS  Google Scholar 

  17. McLaughlin P, Hagemeister FB, Grillo-Lopez AJ: Rituximab in indolent lymphoma: the single-agent pivotal trial. Semin Oncol 1999, 26(suppl 14):79–87.

    PubMed  CAS  Google Scholar 

  18. Solal-Celigny P, Lepage E, Brousse N, et al.: Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe de’Etude des Lymphomes Folliculaires 86 trial. J Clin Oncol 1998, 16:2332–2338.

    PubMed  CAS  Google Scholar 

  19. Dana BW, Unger J, Fisher RI, et al.: A randomized study of alpha-interferon consolidation in patients with low-grade lymphoma who have responded to Pro-MACE-MOPP (Day 1–8) [abstract]. Proc ASCO 1998, 17:3a.

    Google Scholar 

  20. Rohatiner AZA, Gregory W, Peterson B, et al.: Meta-analysis (MA) of randomized trials evaluating the role of interferon (IFN) as treatment for follicular lymphoma (FL) [abstract]. Proc ASCO 1998, 17:4a.

    Google Scholar 

  21. Bendandi M, Gocke CD, Kobrin CB, et al.: Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 1999, 5:1171–1177.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, 10021, New York, NY, USA

    Carol S. Portlock MD

Authors
  1. Carol S. Portlock MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Portlock, C.S. New developments in lymphoma clinical trials. Curr Oncol Rep 2, 154–156 (2000). https://doi.org/10.1007/s11912-000-0087-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-000-0087-8

Keywords

Search

Navigation